Cargando…

c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study

Relationships between c-Rel and GCB-DLBCLs remain unclear. We found that strong c-Rel DNA-binding activity was mostly found in GCBs on two independent series of 48 DLBCLs and 66 DLBCLs, the latter issued from the GHEDI series. c-Rel DNA-binding activity was associated with increased REL mRNA express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faumont, Nathalie, Taoui, Oussama, Collares, Davi, Jais, Jean-Philippe, Leroy, Karen, Prévaud, Léa, Jardin, Fabrice, Molina, Thierry J., Copie-Bergman, Christiane, Petit, Barbara, Gourin, Marie-Pierre, Bordessoule, Dominique, Troutaud, Danielle, Baud, Véronique, Feuillard, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095348/ https://www.ncbi.nlm.nih.gov/pubmed/33959502 http://dx.doi.org/10.3389/fonc.2021.638897

Ejemplares similares

P1285: IN VIVO IMPACT OF ABERRANT OVEREXPRESSION OF C-REL NF-ΚB SUBUNIT IN GERMINAL CENTER B-LYMPHOCYTES: A TUMOR ONCOGENIC EVENT IN GCB-DLBCLS
por: Prévaud, L., et al.
Publicado: (2022)

Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions
por: Baud, Véronique, et al.
Publicado: (2016)

Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors
por: Ibrahim, Dina, et al.
Publicado: (2022)

Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
por: Paunescu, Alexandra-Cristina, et al.
Publicado: (2021)

Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
por: Paunescu, Alexandra‑Cristina, et al.
Publicado: (2021)

Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas
por: Dubanet, Lydie, et al.
Publicado: (2015)

The NF-κB RelA Transcription Factor Is Critical for Regulatory T Cell Activation and Stability
por: Ronin, Emilie, et al.
Publicado: (2019)

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies
por: Cabannes‐Hamy, Aurélie, et al.
Publicado: (2018)

NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB
por: Kabacaoglu, Derya, et al.
Publicado: (2019)

RelB and Neuroinflammation
por: Mockenhaupt, Karli, et al.
Publicado: (2021)

Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma
por: Vincent-Fabert, Christelle, et al.
Publicado: (2019)

Endogenous Neurotrophins and Trk Signaling in Diffuse Large B Cell Lymphoma Cell Lines Are Involved in Sensitivity to Rituximab-Induced Apoptosis
por: Bellanger, Cynthia, et al.
Publicado: (2011)

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
por: Lemoine, Jean, et al.
Publicado: (2023)

Frequent Engagement of RelB Activation Is Critical for Cell Survival in Multiple Myeloma
por: Cormier, Françoise, et al.
Publicado: (2013)

c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells
por: David, Amandine, et al.
Publicado: (2017)

RelB and RelE of Escherichia coli Form a Tight Complex That Represses Transcription via the Ribbon–Helix–Helix Motif in RelB
por: Overgaard, Martin, et al.
Publicado: (2009)

The Alternative RelB NF-kB Subunit Exerts a Critical Survival Function upon Metabolic Stress in Diffuse Large B-Cell Lymphoma-Derived Cells
por: Nuan-Aliman, Stéphanie, et al.
Publicado: (2022)

Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles
por: Dubois, Sydney, et al.
Publicado: (2019)

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
por: Bonnet, Christophe, et al.
Publicado: (2022)

S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY
por: Houot, Roch, et al.
Publicado: (2023)

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis
por: Thieblemont, Catherine, et al.
Publicado: (2023)

The structure of DarB in complex with Rel(NTD) reveals nonribosomal activation of Rel stringent factors
por: Ainelo, Andres, et al.
Publicado: (2023)

Borrelia [bә-rel′e-ә]
Publicado: (2009)

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
por: Al Tabaa, Yassine, et al.
Publicado: (2023)

Reproducing indolent B-cell lymphoma transformation with T-cell immunosuppression in LMP1/CD40-expressing mice
por: Vincent-Fabert, Christelle, et al.
Publicado: (2019)

A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?
por: Troadec, E, et al.
Publicado: (2017)

The Unsolved Puzzle of c-Rel in B Cell Lymphoma
por: Kober-Hasslacher, Maike, et al.
Publicado: (2019)

The mitochondrial localization of RelB and NFATx in immature T cells
por: Stasik, Izabela, et al.
Publicado: (2008)

RelB regulates the homeostatic proliferation but not the function of Tregs
por: Zhou, Shuping, et al.
Publicado: (2020)

Yeast Derived LysA2 Can Control Bacterial Contamination in Ethanol Fermentation
por: Kim, Jun-Seob, et al.
Publicado: (2018)

Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study
por: Bonnet, Antoine, et al.
Publicado: (2022)

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma
por: Li, Ling, et al.
Publicado: (2015)

p50–NF-κB Complexes Partially Compensate for the Absence of RelB: Severely Increased Pathology in p50(−) (/−) relB(−) (/−)Double-knockout Mice
por: Weih, Falk, et al.
Publicado: (1997)

ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study
por: Sibon, David, et al.
Publicado: (2022)

Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network
por: Saliba, Jennifer, et al.
Publicado: (2023)

The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma
por: Lee, Dong Whan, et al.
Publicado: (2013)

Differential RelA- and RelB-dependent gene transcription in LTβR-stimulated mouse embryonic fibroblasts
por: Lovas, Agnes, et al.
Publicado: (2008)

RelB-Dependent Stromal Cells Promote T-Cell Leukemogenesis
por: dos Santos, Nuno R., et al.
Publicado: (2008)

Involvement of REL/NF-B Transcription Factors in Cellular Senescence
por: Bernard, David, et al.
Publicado: (2001)

Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients
por: Labonté, Laura E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8gggcnj4krhpjkm4r56a2dbb5g